153 related articles for article (PubMed ID: 6383598)
1. Effect of hypolipidemic peroxisome proliferators on unscheduled DNA synthesis in cultured hepatocytes and on mutagenesis in Salmonella.
Glauert HP; Reddy JK; Kennan WS; Sattler GL; Rao VS; Pitot HC
Cancer Lett; 1984 Sep; 24(2):147-56. PubMed ID: 6383598
[TBL] [Abstract][Full Text] [Related]
2. Properties of hypolipidemic peroxisome proliferators in the lymphocyte [3H]thymidine and Salmonella mutagenesis assays.
Warren JR; Simmon VF; Reddy JK
Cancer Res; 1980 Jan; 40(1):36-41. PubMed ID: 6765917
[No Abstract] [Full Text] [Related]
3. Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster.
Lake BG; Evans JG; Cunninghame ME; Price RJ
Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):241-7. PubMed ID: 8013414
[TBL] [Abstract][Full Text] [Related]
4. Genotoxic effects of selected peroxisome proliferators.
Reisenbichler H; Eckl PM
Mutat Res; 1993 Apr; 286(2):135-44. PubMed ID: 7681524
[TBL] [Abstract][Full Text] [Related]
5. Effect of peroxisome proliferator carcinogens on unscheduled DNA synthesis in rat hepatocytes determined by autoradiography.
Cattley RC; Richardson KK; Smith-Oliver T; Popp JA; Butterworth BE
Cancer Lett; 1986 Dec; 33(3):269-77. PubMed ID: 3802057
[TBL] [Abstract][Full Text] [Related]
6. Induction of unscheduled DNA synthesis in primary rat hepatocytes by benzidine-congener-derived azo dyes in the in vitro and in vivo/in vitro assays.
Joachim F; Decad GM
Mutat Res; 1984 May; 136(2):147-52. PubMed ID: 6371517
[TBL] [Abstract][Full Text] [Related]
7. Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis.
James NH; Roberts RA
Carcinogenesis; 1996 Aug; 17(8):1623-32. PubMed ID: 8761418
[TBL] [Abstract][Full Text] [Related]
8. Genotoxic activity of the N-acetylated metabolites of the food mutagens 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ).
Brunborg G; Holme JA; Alexander J; Becher G; Hongslo JK
Mutagenesis; 1988 Jul; 3(4):303-9. PubMed ID: 3062317
[TBL] [Abstract][Full Text] [Related]
9. On the mechanism of the hepatocarcinogenicity of peroxisome proliferators.
Nilsson R; Beije B; Préat V; Erixon K; Ramel C
Chem Biol Interact; 1991; 78(2):235-50. PubMed ID: 2040027
[TBL] [Abstract][Full Text] [Related]
10. Genotoxicity of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP): formation of 2-hydroxamino-PhIP, a directly acting genotoxic metabolite.
Holme JA; Wallin H; Brunborg G; Søderlund EJ; Hongslo JK; Alexander J
Carcinogenesis; 1989 Aug; 10(8):1389-96. PubMed ID: 2665964
[TBL] [Abstract][Full Text] [Related]
11. Comitogenicity of eicosanoids and the peroxisome proliferator ciprofibrate in cultured rat hepatocytes.
Hong JT; Glauert HP
J Cell Physiol; 1996 Nov; 169(2):309-19. PubMed ID: 8908198
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of WY-14,643 to clofibric acid, nafenopin and LY171883.
Eacho PI; Lanier TL; Brodhecker CA
Carcinogenesis; 1991 Sep; 12(9):1557-61. PubMed ID: 1893515
[TBL] [Abstract][Full Text] [Related]
13. Comparative genotoxicity studies of the flame retardant tris(2,3-dibromopropyl)phosphate and possible metabolites.
Holme JA; Søderlund EJ; Hongslo JK; Nelson SD; Dybing E
Mutat Res; 1983 Dec; 124(3-4):213-24. PubMed ID: 6686285
[TBL] [Abstract][Full Text] [Related]
14. Genotoxicity of apomorphine and various catecholamines in the Salmonella mutagenicity test (Ames test) and in tests for primary DNA damage using DNA repair-deficient B. subtilis strains (rec assay).
Suter W; Matter-Jaeger I
Mutat Res; 1984 Jul; 137(1):17-28. PubMed ID: 6431280
[TBL] [Abstract][Full Text] [Related]
15. Effect of peroxisome proliferators on intrachromosomal and interchromosomal recombination in yeast.
Schiestl RH; Reddy JK
Carcinogenesis; 1990 Jan; 11(1):173-6. PubMed ID: 2403857
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferators do not increase DNA synthesis in purified rat hepatocytes.
Parzefall W; Berger W; Kainzbauer E; Teufelhofer O; Schulte-Hermann R; Thurman RG
Carcinogenesis; 2001 Mar; 22(3):519-23. PubMed ID: 11238195
[TBL] [Abstract][Full Text] [Related]
17. The peroxisome proliferations WY-14,643 and methylclofenapate induce hepatocyte ploidy alterations and ploidy-specific DNA synthesis in F344 rats.
Miller RT; Shah RS; Cattley RC; Popp JA
Toxicol Appl Pharmacol; 1996 Jun; 138(2):317-23. PubMed ID: 8658533
[TBL] [Abstract][Full Text] [Related]
18. Lack of release from hepatocytes in vitro or excretion in vivo of mutagenic chrysoidine metabolites.
Sandhu P; Chipman JK
Toxicol Lett; 1991 Sep; 58(1):43-50. PubMed ID: 1897005
[TBL] [Abstract][Full Text] [Related]
19. Use of primary cultures of adult rat hepatocytes to investigate mechanisms of action of nafenopin, a hepatocarcinogenic peroxisome proliferator.
Bieri F; Bentley P; Waechter F; Stäubli W
Carcinogenesis; 1984 Aug; 5(8):1033-9. PubMed ID: 6146407
[TBL] [Abstract][Full Text] [Related]
20. The peroxisome proliferators are hepatocyte mitogens in chemically-defined media: glucocorticoid-induced PPAR alpha is linked to peroxisome proliferator mitogenesis.
Plant NJ; Horley NJ; Savory RL; Elcombe CR; Gray TJ; Bell DR
Carcinogenesis; 1998 May; 19(5):925-31. PubMed ID: 9635884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
